Merge Healthcare announced that it may continue to trade on the Nasdaq stock exchange.
The company had been trading under $1 for 30 consecutive days, which put it out of compliance with a minimum-bid requirement, according to an April warning from the stock market. Merge had until Sept. 29 to close trading above $1 for 10 consecutive days, which it attained this month, the company said in a news release. At deadline, the stock was trading at about $1.
The Milwaukee-based company develops medical-imaging software and information-management systems.